Amivas (US) LLC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2016-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.amivas.com
Clinical Trials
3
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Study Evaluating the Efficacy and Safety of Artesunate
Phase 2
Not yet recruiting
- Conditions
- CMV Infection
- Interventions
- First Posted Date
- 2025-02-28
- Last Posted Date
- 2025-04-23
- Lead Sponsor
- Amivas Inc.
- Target Recruit Count
- 90
- Registration Number
- NCT06853184
Evaluation of Artesunate in Infants Being Treated for Severe Malaria
Recruiting
- Conditions
- Malaria
- First Posted Date
- 2024-08-15
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- Amivas (US), LLC
- Target Recruit Count
- 15
- Registration Number
- NCT06555809
- Locations
- 🇫🇷
Hôpital Cochin Port Royal, Paris, France
Observational Study of the Safety of Intravenous Artesunate Treatment of Pregnant Women and Their Infants
Recruiting
- Conditions
- PregnancyMalaria
- First Posted Date
- 2022-03-18
- Last Posted Date
- 2024-01-30
- Lead Sponsor
- Amivas (US), LLC
- Target Recruit Count
- 25
- Registration Number
- NCT05285735
- Locations
- 🇺🇸
4C Pharma Solutions, Piscataway, New Jersey, United States
News
No news found